Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Tong-Xie-Yao-Fang in Regulating Treg/Th17 Imbalance of Diarrhea-predominant Irritable Bowel Syndrome by Trp-Kyn-AhR Pathway

NCT06737666 is registered in ClinicalTrials.gov with Xiyuan Hospital of China Academy of Chinese Medical Sciences as lead sponsor.

NCT NCT06737666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06737666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Tong-Xie-Yao-Fang in Regulating Treg/Th17 Imbalance of Diarrhea-predominant Irritable Bowel Syndrome by Trp-Kyn-AhR Pathway
Lead sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase
Phase 1
Overall status
Recruiting
Start date
May 29, 2023
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea-predominant irritable bowel syndrome